Nxera Pharma Co., Ltd. (OTCMKTS:SOLTF – Get Free Report) passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $9.30 and traded as low as $7.75. Nxera Pharma shares last traded at $7.75, with a volume of 110 shares.
Nxera Pharma Stock Up 6.9 %
The company’s 50 day simple moving average is $8.55 and its 200-day simple moving average is $9.30.
Nxera Pharma Company Profile
Nxera Pharma Co, Ltd. develops and sells biopharmaceutical products in Japan, Switzerland, the United States, Bermuda, and the United Kingdom. Its product portfolio products include Ultibro/Breezhaler and Seebri/Breezhaler for the treatment of chronic obstructive pulmonary disease; Enerzair and Breezhaler for the treatment of asthma; ORAVI, a novel formulation for the treatment of oropharyngeal candidiasis; and PIVLAZ for the treatment of cerebral vasospasm indications.
Featured Articles
- Five stocks we like better than Nxera Pharma
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Palantir Cracks $50, Is There Still Time to Get on Board?
- What is the Hang Seng index?
- Insider Buying Signals Upside for These 3 Stocks
- 3 Stocks to Consider Buying in October
- These 2 Big Players Are Set to Compete With Elon Musk’s Starlink
Receive News & Ratings for Nxera Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nxera Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.jpg?v=20230227112657&h=45&w=95&zc=2){kind=logo}
